Edward L Hannan1, Yifeng Wu1, Jacqueline Tamis-Holland2, Alice K Jacobs3, Peter B Berger4, Frederick S K Ling5, Gary Walford6, Ferdinand J Venditti7, Spencer B King8. 1. Department of Health policy, Management, and Behavior, School of Public Health, University at Albany, State University of New York, Albany, New York. 2. Department of Cardiology, Mount Sinai St. Luke's Hospital, New York, New York. 3. Department of Cardiology, Boston Medical Center, Boston, Massachusetts. 4. Great Neck, NY. 5. Department of Cardiology, University of Rochester Medical Center, Rochester, New York. 6. Department of Cardiology, Johns Hopkins University, Baltimore, Maryland. 7. Department of Administration, Albany Medical Center, Albany, New York. 8. Department of Cardiology, St. Joseph's Health System, Atlanta, Georgia.
Abstract
OBJECTIVES: To compare mortality for women and men hospitalized with ST-elevation myocardial infarction (STEMI) by age and revascularization status. BACKGROUND: There is little information on the mortality of men and women not undergoing revascularization, and the impact of age on relative male-female mortality needs to be revisited. METHODS AND RESULTS: An observational database of 23,809 patients with STEMI presenting at nonfederal New York State hospitals between 2013 and 2015 was used to compare risk-adjusted inhospital/30-day mortality for women and men and to explore the impact of age on those differences. Women had significantly higher mortality than men overall (adjusted odds ratio [AOR] = 1.15, 95% CI [1.04, 1.28]), and among patients aged 65 and older. Women had lower revascularization rates in general (AOR = 0.64 [0.59, 0.69]) and for all age groups. Among revascularized STEMI patients, women overall (AOR = 1.30 [1.10, 1.53]) and over 65 had higher mortality than men. Among patients not revascularized, women between the ages of 45 and 64 had lower mortality (AOR = 0.68 [0.48, 0.97]). CONCLUSIONS: Women with STEMI, and especially older women, had higher inhospital/30-day mortality rates than their male counterparts. Women had higher mortality among revascularized patients, but not among patients who were not revascularized.
OBJECTIVES: To compare mortality for women and men hospitalized with ST-elevation myocardial infarction (STEMI) by age and revascularization status. BACKGROUND: There is little information on the mortality of men and women not undergoing revascularization, and the impact of age on relative male-female mortality needs to be revisited. METHODS AND RESULTS: An observational database of 23,809 patients with STEMI presenting at nonfederal New York State hospitals between 2013 and 2015 was used to compare risk-adjusted inhospital/30-day mortality for women and men and to explore the impact of age on those differences. Women had significantly higher mortality than men overall (adjusted odds ratio [AOR] = 1.15, 95% CI [1.04, 1.28]), and among patients aged 65 and older. Women had lower revascularization rates in general (AOR = 0.64 [0.59, 0.69]) and for all age groups. Among revascularized STEMI patients, women overall (AOR = 1.30 [1.10, 1.53]) and over 65 had higher mortality than men. Among patients not revascularized, women between the ages of 45 and 64 had lower mortality (AOR = 0.68 [0.48, 0.97]). CONCLUSIONS:Women with STEMI, and especially older women, had higher inhospital/30-day mortality rates than their male counterparts. Women had higher mortality among revascularized patients, but not among patients who were not revascularized.
Authors: Anna E Bortnick; Muhammad Shahid; Sanyog G Shitole; Michael Park; Anna Broder; Carlos J Rodriguez; James Scheuer; Robert Faillace; Jorge R Kizer Journal: Clin Cardiol Date: 2020-07-28 Impact factor: 2.882
Authors: Samian Sulaiman; Akram Kawsara; Mohamed O Mohamed; Harriette G C Van Spall; Nadia Sutton; David R Holmes; Mamas A Mamas; Mohamad Alkhouli Journal: J Am Heart Assoc Date: 2021-09-17 Impact factor: 5.501